In this recent study by Bachawal et al., authors used the multimodal imaging capabilities of the Vevo imaging system to evaluate the aggressiveness of ductal carcinoma in situ (DCIS) through B7-H3 targeted ultrasound and photoacoustic molecular imaging.
Here the authors utilized the photoacoustic imaging (PA) capabilities of the Vevo LAZR-X to screen donor kidneys for fibrosis prior to implanting them into chronic kidney diseased animal models and patients.
This recent article by Lavaud et al. uses high-frequency ultrasound and spectroscopic photoacoustic imaging (PAI), along with commercially available contrast agents to non-invasively examine metastatic liver lesions.
In this study, Ramasawmy et al.1 sought to compare 9 Tesla (T) MRI, Benchtop (1T) MRI, Vevo US and BLI in the ability to monitor and detect tumor growth in a xenograft colorectal metastasis model in the mouse liver.